MEMBER'S LOGINX

Remember Username
Keep me signed in

(Please do not use this option on a public machine)

Print
Text -Size
RSS
FaceBook
Twitter
LinkedIn
WhatsApp

Home
Todays Market
Indian Stock Market Updates November 20, 2019

Markets will remain closed on 14^th April, 2021 on account of Dr. Baba Saheb Ambedkar Jayanti.

STRIDES PHARMA SCIENCE Surges by 5%; BSE HEALTHCARE Index Up 2.5%
Wed, 20 Nov 02:18 PM

STRIDES PHARMA SCIENCE share price has zoomed 5% and is presently trading at Rs 403.

Meanwhile, the BSE HEALTHCARE Index is at 13,560 (up 2.5%).

Among the top Gainers in the BSE HEALTHCARE Index today are STRIDES PHARMA SCIENCE (up 5.4%) and SUN PHARMA (up 6.9%).

TORRENT PHARMA (down 0.1%) and PROCTER & GAMBLE HEALTH (down 0.2%) are among the top losers today.

Over the last one year, STRIDES PHARMA SCIENCE has moved down from Rs 461 to Rs 403, registering a loss of Rs 58 (down 12.8%).

On the other hand, the BSE HEALTHCARE has moved down from 14,461 to 13,560, loss of 901 points (down 6.4%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were DR. LAL PATHLABS LTD (up 91.1%), ABBOTT INDIA (up 67.3%) and ASTRAZENECA PHARMA (up 58.7%).

Revealed: 3 Stocks for Potentially Massive Gains

What About the Benchmark Indices?

The BSE Sensex is at 40,816 (up 0.5%).

The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 6.9%), INDUSIND BANK (up 4.8%) and RELIANCE IND. (up 2.9%). Other gainers include COAL INDIA (up 1.7%) and MARUTI SUZUKI (up 1.4%). The most traded stocks in the BSE Sensex are YES BANK and TATA MOTORS.

In the meantime, NSE Nifty is at 12,039 (up 0.5%). SUN PHARMA (up 6.7%) and INDUSIND BANK (up 4.7%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved up from 35,775 to 40,816, registering a gain of 5,041 points (up 13.7%).

STRIDES PHARMA SCIENCE Financial Update...

STRIDES PHARMA SCIENCE net profit stood at Rs 2 billion for the quarter ended September 2019, compared to a profit of Rs 316 million a year ago. Net Sales declined 10.0% to Rs 7.2 billion during the period as against Rs 7.9 billion in July-September 2018.

For the year ended March 2018, STRIDES PHARMA SCIENCE reported 58.6% decrease in net profit to Rs 1.3 billion compared to net profit of Rs 3.2 billion during FY17.

Revenue of the company grew 3.0% to Rs 28 billion during FY18.

The current Price to earnings ratio of STRIDES PHARMA SCIENCE, based on rolling 12 month earnings, stands at 12.2x.